CYTOVALE
Categorized is a medical technology company that revolutionizes diagnostics using cell mechanics and machine learning. The company was founded in 2013 by Ajay Shah and Dino Di Carlo and is based in San Francisco, California, United States.
CYTOVALE
Industry:
Artificial Intelligence Health Diagnostics Life Science Machine Learning
Founded:
2013-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.cytovale.com
Total Employee:
11+
Status:
Active
Contact:
562-881-6919
Email Addresses:
[email protected]
Total Funding:
44.59 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Apps For Business Google Maps Microsoft Azure DNS Cloudflare JS
Current Advisors List
Current Employees Featured
Founder
Investors List
Dolby Family Ventures
Dolby Family Ventures investment in Debt Financing - CytoVale
Breakout Ventures
Breakout Ventures investment in Debt Financing - CytoVale
Pathway Bioventures
Pathway Bioventures investment in Debt Financing - CytoVale
Blackhorn Ventures
Blackhorn Ventures investment in Debt Financing - CytoVale
Western Technology Investment
Western Technology Investment investment in Series B - CytoVale
Blackhorn Ventures
Blackhorn Ventures investment in Series B - CytoVale
Breakout Ventures
Breakout Ventures investment in Series B - CytoVale
GRIDS Capital
GRIDS Capital investment in Series B - CytoVale
GRIDS Capital
GRIDS Capital investment in Series B - CytoVale
Breakout Ventures
Breakout Ventures investment in Series B - CytoVale
More informations about "CytoVale"
Company - Cytovale
Rachel is responsible for overseeing all aspects of the Sales organization for Cytovale. She is a performance-driven commercial leader with experience launching first-of-its-kind technologies …See details»
CytoVale - Crunchbase Company Profile & Funding
Organization. CytoVale . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... CytoVale is a medical technology company that focuses on advancing early detection technologies …See details»
Cytovale
The Cytovale system interrogates thousands of cells per second to rapidly assess host immune state and identify disease signatures. Simplified Workflow. A simple workflow with minimal …See details»
Cytovale - LinkedIn
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases.See details»
CytoVale - Funding, Financials, Valuation & Investors
CytoVale is funded by 14 investors. CPP Investments and Sands Capital Ventures are the most recent investors. CytoVale has a post-money valuation in the range of $500M to $1B as of Oct 10, 2024, according to PrivCo. Sign up …See details»
CytoVale - Contacts, Employees, Board Members, Advisors & Alumni
CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases. ... Solutions. Products. Resources. …See details»
How Cytovale Is Set To Transform The Fight Against …
Oct 13, 2021 Sepsis is the leading cause of death worldwide according to the World Health Organization, killing 11 million people each year, many of them children, and disabling many more. But while speedy ...See details»
Cytovale: A Breakthrough Tool in The Fight Against …
Jun 6, 2024 Cytovale offers IntelliSep, the first FDA-approved, rapid sepsis diagnostic test for use in EDs. Its cutting-edge, patented technology requires only 90 seconds of hands-on time by ED staff and generates results in under an …See details»
Cytovale Secures $84 Million Series C to Advance …
Nov 15, 2023 About Cytovale ® Cytovale is committed to improving human health by pioneering early detection technologies powered by insightful assessment of immune activation.See details»
Contact Us - Cytovale
Organization Name * How Did You Hear About Cytovale * Message. Newsletter Subscribe. Sign me up to receive news and communications from Cytovale. Name. This field is for validation …See details»
Cytovale collects $84M to roll out its rapid ER sepsis diagnostic test
Nov 16, 2023 Cytovale announced the first placements of its IntelliSep testing platform this past August. It aims to offer a diagnosis for adult patients showing signs of an infection in under 10 …See details»
Cytovale's FDA-Cleared Sepsis Diagnostic Triages First 5,000 …
Jun 20, 2024 Cytovale is based in San Francisco and venture-backed by Norwest Venture Partners, Sands Capital and Global Health Investment Corporation (GHIC). For more …See details»
Finding Opportunities When Curveballs Come Your Way
Stay agile as an organization to make the most of these moments. Cultivate a network of trusted advisors and harness your technical skills to sift through their advice, identifying and focusing …See details»
Careers - Cytovale
At Cytovale, we are an extraordinary team of biologists, data scientists, engineers, former care providers, financiers, and just plain caring people with a vision for how to make very complex, …See details»
Cytovale Begins Enrollment in FDA 510(k) Clinical Validation Study …
Jun 2, 2021 About Cytovale Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases.See details»
Cytovale Reveals 10-Minute, 510(k) Pending Cytovale System and ...
Jul 25, 2022 Cytovale will unveil its 510(k) pending Cytovale system and 10-minute IntelliSep sepsis risk stratification test, and new supporting data, at AACC. Cytovale Reveals 10-Minute, …See details»
Cytovale
Cytovale’s Patented ‘Squeeze’ Under flow, precision microfluidic features apply precise and uniform hydrodynamic forces to tens of thousands of individual cells, and the resulting cellular …See details»
Sepsis Alliance Institute: Cytovale: Sepsis Luminary
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Cytovale’s FDA-cleared IntelliSep …See details»
Our Science - Cytovale
The Cytovale System uses high-throughput image analysis and machine learning to examine biologically relevant features in cell images, translating them into a score that reflects …See details»